Research Topics
Genomes and GenesSpecies | A AchironSummaryAffiliation: Tel Aviv University Country: Israel Publications
| Collaborators
|
Detail Information
Publications
T-cell vaccination in multiple sclerosisAnat Achiron
Center for Multiple Sclerosis, Sheba Medical Center, Tel Hashomer 52621, Israel
Autoimmun Rev 3:25-32. 2004..Specifically, it is important to examine the effect of early TCV, given after the first episode suggestive of the disease, in order to prevent the process of epitope spreading...
Unique gene expression patterns in human T-cell lines generated from multiple sclerosis patients by stimulation with a synthetic MOG peptideMathilda Mandel
Blood Center, Sheba Medical Center, Tel Hashomer 52621, Israel
Clin Dev Immunol 12:203-9. 2005....
Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cellsMichael Gurevich
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
BMC Med Genomics 2:46. 2009..Similar approach can be also useful for dealing with other autoimmune diseases that characterized by relapsing-remitting nature...
Fluoxetine treatment for weight reduction in steroid-induced obesity: a pilot study in myasthenia gravis patientsA Achiron
Sheba Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University Tel Hashomer, Israel
Eur Neuropsychopharmacol 9:111-3. 1999..8 to 32.2 kg/m2 over the study period. No significant side effects were noted. We conclude that patients suffering from steroid-induced obesity respond to fluoxetine treatment of overweight by significant weight loss...
Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosisA Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Tel Aviv University, Israel
Clin Exp Immunol 149:235-42. 2007..Our findings provide a basis for monitoring patients by prediction of disease outcome and can be incorporated into clinical decision-making in relapsing-remitting MS...
Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosisA Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel
Autoimmun Rev 5:517-22. 2006....
Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosisAnat Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Israel
Mult Scler 9:486-91. 2003..Identifying the rate of progression of disability for an individual patient early in the disease process can influence treatment decisions as well as enable monitoring of the disease overtime...
Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activityAnat Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer 52621, Israel
Ann Neurol 55:410-7. 2004....
Cognitive changes in early MS: a call for a common frameworkA Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, 52621, Israel, affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Israel
J Neurol Sci 245:47-51. 2006..The present review proposes a framework aimed to help neurologists in approaching cognitive impairment in early MS and stimulate discussions and evaluations of the suggested recommendations...
Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosisAnat Achiron
Multiple Sclerosis Center, Sheba Medical Center, Sacker School of Medicine, Tel Aviv University, Tel Aviv, Israel, Tel Hashomer 52621, Israel
J Neurol 251:1133-7. 2004..Further randomized double-blind studies are needed to confirm our findings...
T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patientsA Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Israel
Clin Immunol 113:155-60. 2004..TCV could serve as a potential alternative therapy for this subgroup of nonresponders patients...
Bone strength in multiple sclerosis: cortical midtibial speed-of-sound assessmentAnat Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Mult Scler 10:488-93. 2004..05). Bone strength was preserved in MS patients. In a subgroup of female patients increased SOS was conceivably related to spasticity...
Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trialAnat Achiron
Multiple Sclerosis Center and Neuroradiology Unit, Sheba Medical Center, Tel Hashomer 52621, Israel
Arch Neurol 61:1515-20. 2004....
[Multiple sclerosis and anti-phospholipid syndrome--one or two diseases?]Anat Achiron
The Center for Multiple Sclerosis, Sheba Medical Center, Tel Hashomer
Harefuah 143:724-6, 766, 765. 2004..The current review approaches this problem and discusses whether multiple sclerosis and anti-phospholipid syndrome are actually one or two diseases...
Predicting the course of relapsing-remitting MS using longitudinal disability curvesAnat Achiron
Multiple Sclerosis, Center Sheba Medical Center affiliated to Tel Aviv University, Sackler School of Medicine, Israel, Tel Hashomer, Israel
J Neurol 251:v65-v68. 2004..The aim of this review is to present longitudinal disability curves enabling the assessment of disease progression in patients with relapsing-remitting (RR)MS...
Understanding autoimmune mechanisms in multiple sclerosis using gene expression microarrays: treatment effect and cytokine-related pathwaysA Achiron
Sheba Medical Center, Tel Hashomer, and Sackler School of Medicine, Tel Aviv University, 52621, Israel
Clin Dev Immunol 11:299-305. 2004..Our results indicate that cytokine-associated genes are involved in various pathogenic pathways in MS and also related to immunomodulatory treatment effects...
Does the flap of a butterfly's wings in Brazil set off a tornado in Texas?--The JC Virus Story in multiple sclerosisAnat Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Israel
Isr Med Assoc J 7:283-5. 2005
Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curvesA Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer 52621, Israel
J Neurol Neurosurg Psychiatry 76:744-9. 2005..The present study aimed to identify correlations between cognitive tests and disease duration, construct longitudinal cognitive curves, and assess pattern of change over time...
Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapseAnat Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, 52621, Israel
Ann N Y Acad Sci 1107:155-67. 2007..This suggests that the inflammatory process in active disease is targeted by inhibition of proapoptotic and repression of antiapoptotic genes that allow prolonged abnormal immune responses...
Prolonged response times characterize cognitive performance in multiple sclerosisA Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Israel
Eur J Neurol 14:1102-8. 2007..We conclude that in MS prolonged response times on a range of cognitive tasks signify abnormal conduction within demyelinative tracts...
Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosisA Achiron
Multiple Sclerosis Center, Sheba Medical Center, Ramat Gan, Israel
J Neuroimmunol 102:26-31. 2000..The results suggest that dexanabinol may provide an alternative mode of treatment for acute exacerbations of multiple sclerosis (MS)...
Immunoglobulin treatment in refractory Myasthenia gravisA Achiron
Neuroimmunology Unit, Sheba Medical Center, Tel Hashomer, 52621 Israel
Muscle Nerve 23:551-5. 2000..01). Intravenous Ig therapy seems to be highly potent for inducing rapid improvement in refractory myasthenia during acute deterioration as well as for maintaining remission...
Multiple sclerosis-from probable to definite diagnosis: a 7-year prospective studyA Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer 52621, Israel
Arch Neurol 57:974-9. 2000..To investigate the rate of progression from probable to clinically definite multiple sclerosis (MS) and to define patients who had rapidly (within 1 year) progressed to a definite diagnosis...
Characterization of multiple sclerosis traits: nuclear receptors (NR) impaired apoptosis pathway and the role of 1-α 25-dihydroxyvitamin D3Anat Achiron
Multiple Sclerosis Center, Sheba Medical Center, and Sackler School of Medicine Tel Aviv University, Israel
J Neurol Sci 311:9-14. 2011..These findings prove a role for Vit D(3) as a possible therapeutic intervention in MS patients aimed to activate the repressed apoptosis and enhance better control of the disease...
Cancer incidence in multiple sclerosis and effects of immunomodulatory treatmentsAnat Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Sacker School of Medicine, Tel Aviv University, Tel Aviv, Israel
Breast Cancer Res Treat 89:265-70. 2005..122 and 0.072, respectively). Further study is needed to assess possible associations between long-term exposure to the novel immunomodulatory treatments in MS and rate of cancer...
Intravenous immunoglobulin and multiple sclerosisAnat Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Israel
Clin Rev Allergy Immunol 29:247-54. 2005..In the current review, we summarize the up-to-date data related to IVIg clinical trials in MS, and the suggested mechanisms of action by which IVIg modulates the relevant immunological pathways impaired in MS...
Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosisAnat Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Israel
Neurobiol Dis 38:201-9. 2010....
Brain MRI lesion load quantification in multiple sclerosis: a comparison between automated multispectral and semi-automated thresholding computer-assisted techniquesAnat Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Israel
Magn Reson Imaging 20:713-20. 2002..The MSA multispectral technique is a promising tool for evaluating MS patients. Non-biased recognition and delineation algorithms enable high accuracy, low intra-and inter-observer variances and fast assessment of MS related lesion load...
Gender effects in relapsing-remitting multiple sclerosis: correlation between clinical variables and gene expression molecular pathwaysA Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Israel
J Neurol Sci 286:47-53. 2009..Our findings open possibilities to explore gender-dependent immunomodulatory treatments that will be based on gene expression mechanisms that set the difference between male and female RRMS patients...
Cognitive impairment in probable multiple sclerosisA Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, 52621 Israel
J Neurol Neurosurg Psychiatry 74:443-6. 2003..To evaluate and characterise cognitive impairment in the very early stage of multiple sclerosis (MS), in which patients are still diagnosed as suffering from probable MS...
[Physical activity: positive impact on brain plasticity]Anat Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Israel
Harefuah 147:252-5, 276. 2008..Physical activity should be employed as a tool to improve neural function in healthy subjects and in patients suffering from neurological damage...
Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: in-vitro high-throughput gene expression studyM Gurevich
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Israel
J Neuroimmunol 221:87-94. 2010..These findings were demonstrated mainly via the NFkB pathway. Analysis of PBMC subpopulations identified activation of Th2 response in CD14+ and CD4+ cells and suppression of proliferation in CD8+ cells...
Analysis of allelic association between D6S461 marker and multiple sclerosis in Ashkenazi and Iraqi Jewish patientsY Shinar
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Israel
J Mol Neurosci 11:265-9. 1998..5% of the 260-bp allele (n = 121, p = 0.045). The results suggest that the D6S461 region may contain a locus contributing to an early onset of relapsing-remitting MS...
Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosusM Mandel
Blood Bank, Sheba Medical Centre, Tel Hashomer, Israel
Clin Exp Immunol 138:164-70. 2004..These results provide insights into the genetic pathways underlying autoimmune diseases, and identify specific disease-associated signatures that may enable targetted disease-related specific therapies to be developed...
Late-onset multiple sclerosisM L Polliack
Multiple Sclerosis Center, Sheba Medical Center, Tel-Hashomer, Israel
J Am Geriatr Soc 49:168-71. 2001....
Effect of a cognitive task on postural control in patients with a clinically isolated syndrome suggestive of multiple sclerosisA Kalron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer Israel and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Eur J Phys Rehabil Med 47:579-86. 2011..As postural control consumes attentional resources, it is essential to test stability during a cognitive task...
Gene expression studies in systemic lupus erythematosusM Mandel
Blood Center, Sheba Medical Center, Tel Hashomer, Israel
Lupus 15:451-6. 2006....
Molecular profiling of glatiramer acetate early treatment effects in multiple sclerosisAnat Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Israel
Dis Markers 27:63-73. 2009..Glatiramer acetate (GA, Copaxone) has beneficial effects on the clinical course of relapsing-remitting multiple sclerosis (RRMS). However, the exact molecular mechanisms of GA effects are only partially understood...
Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patientsY Shinar
Heller Institute of Medical Research, Sheba Medical Center, Tel Hashomer, Israel
Genes Immun 4:197-203. 2003..In conclusion, non-Asheknazi MS patients carrying one mutated MEFV gene, particularly M694V, expressed rapid progression to disability. The expressed mutation may increase inflammatory damage inflicted by autoimmune responses...
Sex-related differences in the development of the human fetal corpus callosum: in utero ultrasonographic studyR Achiron
Diagnostic Ultrasound Unit, Department of Obstetrics and Gynecology, The Chaim Sheba Medical Center, Tel Hashomer, and Faculty of Medicine, Tel Aviv University, Israel
Prenat Diagn 21:116-20. 2001..These findings support previous studies suggesting sex dimorphism of human CC and raise the possibility that prenatal sex hormones may play a role in determining callosal development...
Chemokine polymorphisms: candidates for MS susceptibility and disease courseA Achiron
Multiple Sclerosis Centre, Sheba Medical Centre, Tel Hashomer, Israel
Int MS J 11:71-7. 2004..This is due to the key role chemokines play in the physiology of inflammation and regulation of central nervous system trafficking across the blood-brain barrier, and their exploitation by certain micro-organisms to initiate infection...
A mutated CCR5 gene may have favorable prognostic implications in MSRami Kantor
Division of Infectious Diseases, Sheba Medical Center, Tel Hashomer, Israel
Neurology 61:238-40. 2003..Progression to disability was prolonged in Delta32CCR5 homozygotes and heterozygotes compared with MS patients with the CCR5 wild-type genotype (p < 0.005). Mutated CCR5 allele may be considered a favorable prognostic factor in MS...
Lessons from randomised direct comparative trialsAnat Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, and Sackler School of Medicine, Tel Aviv University, Israel
J Neurol Sci 277:S19-24. 2009..The results of the direct comparative studies provide evidence that glatiramer acetate and high-dose interferon-beta preparations have comparable clinical efficacy...
Interaction of disease-related antigen-reactive T-cell lines from multiple sclerosis patients with type IV collagen: role of integrin VLA-1 and effects of irradiationIlan Bank
Department of Medicine F, Sheba Medical Center and Tel Aviv University, Tel Hashomer, Israel
J Clin Immunol 22:153-63. 2002..These findings may have important implications for understanding the pathogenesis of MS and how irradiation of potentially pathogenic T cells produces a reagent with possible therapeutic effects in T-cell vaccination (TCV)...
Reflexology treatment relieves symptoms of multiple sclerosis: a randomized controlled studyI Siev-Ner
Complementary Medicine Clinic, Department of Orthopedic Rehabilitation, Sheba Medical Center, Tel-Hashomer, Israel
Mult Scler 9:356-61. 2003..The improvement in the intensity of paresthesias remained significant at three months of follow-up (P = 0.04). CONCLUSIONS: Specific reflexology treatment was of benefit in alleviating motor; sensory and urinary symptoms in MS patients...
Development of the human fetal corpus callosum: a high-resolution, cross-sectional sonographic studyR Achiron
Department of Obstetrics and Gynecology, The Chaim Sheba Medical Center, Tel Hashomer, Israel
Ultrasound Obstet Gynecol 18:343-7. 2001..To establish reference ranges during human pregnancy for normal fetal corpus callosum dimensions...
Effect of interferon-beta-1b on cognitive functions in multiple sclerosisYoram Barak
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Israel
Eur Neurol 47:11-4. 2002..Multiple sclerosis (MS) is recognised as a central nervous system disease also affecting cognition. The rate of cognitive dysfunction in MS is in the range of 45-65% and adversely affect the quality of life...
Cognitive fatigue in multiple sclerosis: findings from a two-wave screening projectYoram Barak
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Israel
J Neurol Sci 245:73-6. 2006..However, the relationship of fatigue to cognitive functions and its impact on quality of life have not been widely studied...
Clone clusters in autoreactive CD4 T-cell lines from probable multiple sclerosis patients form disease-characteristic signaturesMathilda Mandel
Blood Centre, Sheba Medical Centre, Tel Hashomer, 52621, Israel
Immunology 128:287-300. 2009..Analyses of clonal-clustering patterns may potentially aid in subclassification of MS or in characterizing aetiological agents of this disease...
Circulatory neurosteroid levels in underweight female adolescent anorexia nervosa inpatients and following weight restorationD Stein
Pediatric Psychosomatic Department, Chaim Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Eur Neuropsychopharmacol 15:647-53. 2005..DHEA(-S) levels following weight restoration, may in part account for the feeding difficulties in AN, particularly during refeeding...
Lack of evidence for an association between two genetic polymorphisms in the tumor necrosis factor receptor 1 gene and multiple sclerosis in Ashkenazi JewsE Pras
Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel Hashomer, Israel
Eur Neurol 46:153-5. 2001..No significant differences were observed for both polymorphisms between the patients and the controls. These findings suggest that genetic variants in TNFR1 do not play a significant role in Ashkenazi Jews...
Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosisZeev Rotstein
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Tel Aviv University, Israel
Autoimmun Rev 5:511-6. 2006....
Long term safety of IVIg therapy in multiple sclerosis: 10 years experienceUriel Katz
Department of Internal Medicine B, Center for Autoimmune Diseases, The Chaim Sheba Medical Center, Tel Hashomer, 52621, Israel
Autoimmunity 39:513-7. 2006..Adverse events during the loading dose did not predict adverse events during the maintenance phase. No severe adverse events were recorded. We conclude that IVIg is a safe therapy in MS either for short or for long-term periods...
Gait analysis in multiple sclerosis: characterization of temporal-spatial parameters using GAITRite functional ambulation systemUri Givon
Department of Pediatric Orthopaedics, Safra Hospital for Children and Motion Analysis Laboratory, Sheba Medical Center, Tel Hashomer, Israel
Gait Posture 29:138-42. 2009..However, specific characterization of abnormal gait in MS patients has only been described in small groups of patients, mainly using observational tools...
Suicide attempts of schizophrenia patients: a case-controlled study in tertiary careYoram Barak
Abarbanel Mental Health Center, Sackler School of Medicine, Tel Aviv University, Bat Yam, Israel
J Psychiatr Res 42:822-6. 2008..However, there is paucity of data regarding suicide attempts by schizophrenia patients. The aim of the present study was to characterize a large sample of schizophrenia patients in tertiary care who had attempted suicide...
Bowel circulation in normally grown and growth-restricted fetusesZvi Kivilevitch
Ultrasound Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel Hashomer, 52621 Ramat Gan, Israel
J Ultrasound Med 30:1529-37. 2011..The purpose of this study was to characterize bowel blood flow and its relationship with cerebral and placental circulations in normally grown and growth-restricted fetuses...
Effect of craniosacral therapy on lower urinary tract signs and symptoms in multiple sclerosisGil Raviv
Urology Department, Sheba Medical Center, Tel Hashomer, Israel
Complement Ther Clin Pract 15:72-5. 2009..001>p>0.0001). CST was found to be an effective means for treating lower urinary tract symptoms and improving quality of life in MS patients...
Sandlike appearance of Virchow-Robin spaces in early multiple sclerosis: a novel neuroradiologic markerAnat Achiron
Multiple Sclerosis Center, Sheba Medical Center, Tel-Hashomer, Israel
AJNR Am J Neuroradiol 23:376-80. 2002..CONCLUSION: VRSs were more frequent in patients with recent-onset MS than in control subjects. The sandlike appearance of VRSs may be a neuroradiologic marker that reflects early inflammatory changes in MS...
Screening for early cognitive impairment in multiple sclerosis patients using the clock drawing testYoram Barak
The Doly Steindling Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Israel
J Clin Neurosci 9:629-32. 2002..The absence of correlation with total EDSS score coupled with significant correlation with the mental functional system suggests that the CDT may be useful for screening MS patients...
Happiness and neurological diseasesYoram Barak
MS Center, Sheba Medical Center, Tel Hashomer and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 52612, Israel
Expert Rev Neurother 9:445-59. 2009....
Application of spherical harmonics derived space rotation invariant indices to the analysis of multiple sclerosis lesions' geometry by MRIDaniel Goldberg-Zimring
Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Israel
Magn Reson Imaging 22:815-25. 2004..In conclusion, our proposed method circumvents the need for precise patient repositioning and can be advantageous in MRI longitudinal studies of MS patients...
Safety of intravenous immunoglobulin (IVIG) therapyUriel Katz
Center for Autoimmune Diseases, Department of Internal Medicine B, The Chaim Sheba Medical Center, Tel Hashomer 52621, Israel
Autoimmun Rev 6:257-9. 2007..We conclude that IVIg is a safe therapy when given in a slow infusion rate in well-hydrated patients, better avoiding patients with known risk factors...
Can blood gene expression predict which patients with multiple sclerosis will respond to interferon?Naftali Kaminski
Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
PLoS Med 2:e33; quiz e51. 2005
Reduced cancer incidence among patients with schizophreniaYoram Barak
Psychogeriatric Department, Abarbanel Mental Health Center, Bat Yam, Israel
Cancer 104:2817-21. 2005..The current study was performed to evaluate the frequency of cancer in a large cohort of patients with schizophrenia and to determine the standardized incidence ratios (SIRs) of any malignancy in this group...
G-CSF enhances the adhesion of encephalitogenic T cells to extracellular matrix components: a possible mechanism for exacerbation of multiple sclerosisOmri Snir
Faculty of Life Science, Bar-Ilan University, Ramat-Gan, Israel
J Neuroimmunol 172:145-55. 2006..We propose a link between clinical worsening of MS symptoms induced by G-CSF and the hyperstimulation of T cell adhesion to ECM elicited by G-CSF...
Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosisWilliam H Stuart
Peachtree Neurological Clinic, 3200 Downwood Circle, Suite 550, Atlanta, Georgia 30327, USA
Neurology 63:S19-27. 2004..Research is ongoing to identify other appropriate add-on agents (e.g., antigen-specific therapies) to be used in combination with existing DMAs to effectively manage MS...
Breast cancer in women suffering from serious mental illnessYoram Barak
Psychogeriatric Department, Abarbanel Mental Health Center, Bat Yam, Israel
Schizophr Res 102:249-53. 2008..However, it has been argued that psychiatric morbidity itself may be the confounding factor that affects cancer incidence and not particularly schizophrenia...
Human T-lymphotropic virus type-1 (HTLV-1) in Israeli patients and their family relatives and its transmission to ratsMichael Shohat
Department of Dermatology, Rabin Medical Center, Petah T ikva, Israel
Med Microbiol Immunol 195:93-9. 2006....
Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectationsElliot M Frohman
Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
Arch Neurol 62:1519-30. 2005....
Assessment of multiple sclerosis lesions with spherical harmonics: comparison of MR imaging and pathologic findingsDaniel Goldberg-Zimring
Department of Biomedical Engineering, Technion, Israel Institute of Technology, Haifa, Israel
Radiology 235:1036-44. 2005..Mean DSC was significantly higher than 70% (P < .001). SH method provided unbiased lesion volume and added geometric information that may enable a better understanding of the pathogenesis and lesion evolution over time...
Very late-onset schizophrenia-like psychosis: clinical and imaging characteristics in comparison with elderly patients with schizophreniaYoram Barak
Psychogeriatric Department, Abarbanel Mental Health Center, 15 KKL Street, Bat-Yam 59100, Israel
J Nerv Ment Dis 190:733-6. 2002..The authors suggest that VLOSLP is a valid diagnostic entity and that its features imply that involvement of neurodegenerative process may be etiologically relevant to psychosis with onset in late life...
Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosisHillel S Panitch
Neurology Health Care Service, Fletcher Allen Health Care, University of Vermont, Burlington, 05401, USA
Ann Neurol 59:780-7. 2006....
Three-dimensional analysis of the geometry of individual multiple sclerosis lesions: detection of shape changes over time using spherical harmonicsDaniel Goldberg-Zimring
Department of Biomedical Engineering, Technion, Israel Institute of Technology, Haifa, Israel
J Magn Reson Imaging 18:291-301. 2003..CONCLUSION: Quantitative three-dimensional shape analysis can serve as a new tool for monitoring MS lesion activity and study patterns of MS lesion evolution over time...
Dysregulation of affect in multiple sclerosis: new phenomenological approachYermi Harel
Lewenstein Rehabilitation Hospital, Raanana, Israel
Psychiatry Clin Neurosci 61:94-8. 2007..It is concluded that the new phenomenological definition of DyA aids in distinguishing this symptom from other psychopathologies and can serve as a tool for neurologists in defining this unique entity...
Concordance for cognitive impairment: a study of 50 community-dwelling elderly female-female twin pairsYoram Barak
Pyschogeriatric Department, Abarbanel Mental Health Center, Bat Yam, Israel
Compr Psychiatry 44:117-20. 2003....
Alfacalcidol treatment in multiple sclerosisAnat Achiron
Clin Neuropharmacol 26:53. 2003
